0001483426-22-000001.txt : 20220303
0001483426-22-000001.hdr.sgml : 20220303
20220303114802
ACCESSION NUMBER: 0001483426-22-000001
CONFORMED SUBMISSION TYPE: D
PUBLIC DOCUMENT COUNT: 1
ITEM INFORMATION: 06b
FILED AS OF DATE: 20220303
DATE AS OF CHANGE: 20220303
EFFECTIVENESS DATE: 20220303
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: MBio Diagnostics, Inc.
CENTRAL INDEX KEY: 0001483426
IRS NUMBER: 300593627
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
FILING VALUES:
FORM TYPE: D
SEC ACT: 1933 Act
SEC FILE NUMBER: 021-435698
FILM NUMBER: 22707276
BUSINESS ADDRESS:
STREET 1: 5603 ARAPAHOE AVENUE
STREET 2: SUITE 1
CITY: BOULDER
STATE: CO
ZIP: 80303
BUSINESS PHONE: 3039522905
MAIL ADDRESS:
STREET 1: 5603 ARAPAHOE AVENUE
STREET 2: SUITE 1
CITY: BOULDER
STATE: CO
ZIP: 80303
FORMER COMPANY:
FORMER CONFORMED NAME: mBio Diagnostics, Inc.
DATE OF NAME CHANGE: 20100204
D
1
primary_doc.xml
X0708
D
LIVE
0001483426
MBio Diagnostics, Inc.
5603 ARAPAHOE AVENUE
SUITE 1
BOULDER
CO
COLORADO
80303
302-658-7581
DELAWARE
mBio Diagnostics, Inc.
Corporation
true
Nick
Traggis
5603 Arapahoe Avenue, Suite 1
Boulder
CO
COLORADO
80303
Executive Officer
Director
Judith
O'Brien
5603 Arapahoe Avenue, Suite 1
Boulder
CO
COLORADO
80303
Director
Michael
Chang
5603 Arapahoe Avenue, Suite 1
Boulder
CO
COLORADO
80303
Director
Robert
Silverman
5603 Arapahoe Avenue, Suite 1
Boulder
CO
COLORADO
80303
Director
Christopher
Myatt
5603 Arapahoe Avenue, Suite 1
Unit 120
Boulder
CO
COLORADO
80303
Director
Andrew
Drenick
5603 Arapahoe Avenue, Suite 1
Boulder
CO
COLORADO
80303
Director
Biotechnology
Decline to Disclose
- 06b
false
2022-02-18
false
true
true
false
0
9000000
6120000
2880000
The total offering amount includes convertible promissory notes convertible into shares of the company's capital stock.
false
12
0
0
0
false
MBio Diagnostics, Inc.
/s/ Nick Traggis
Nick Traggis
CEO, by Tyler Hayden, Attorney-in-Fact
2022-03-03